Protalix Biotherapeutics, Inc. (PLX)
2.21
0.00 (0.00%)
USD |
NYAM |
Mar 19, 14:24
Protalix Biotherapeutics EPS Diluted (Quarterly) : -0.0684 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | -0.7326 |
| Lisata Therapeutics, Inc. | -0.3344 |
| OraSure Technologies, Inc. | -0.2695 |
| Nephros, Inc. | 0.0055 |
| Agenus, Inc. | -0.301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.504M |
| Revenue (Quarterly) | 9.122M |
| Total Expenses (Quarterly) | 14.63M |
| Enterprise Value | 155.08M |
| Gross Profit Margin (Quarterly) | 49.36% |
| Profit Margin (Quarterly) | -60.34% |
| Earnings Yield | -3.82% |
| Normalized Earnings Yield | -3.824 |